Literature DB >> 19190046

Variables determining outcome in total hip replacement surgery.

O Rolfson1, L E Dahlberg, J-A Nilsson, H Malchau, G Garellick.   

Abstract

In this study we hypothesised that anxiety/depression, one of five dimensions in the health-related quality of life (HRQoL) measurement tool EQ-5D, could predict outcome after total hip replacement surgery. Pre-operative and one-year post-operative data from the Swedish Hip Arthroplasty Register, including 6158 patients with primary osteoarthritis of the hip, were analysed. In order to examine the association between anxiety and outcome with respect to pain and satisfaction an analysis of covariance was used. The pre-operative EQ-5D anxiety/depression dimension was a strong predictor for pain relief and patient satisfaction (p < 0.001). Orthopaedic surgeons involved in the care of patients eligible for total hip replacement surgery should be aware that mental health may influence post-operative pain and HRQoL. An appropriate assessment of mental health may enable a modification in the way these patients are managed in order to optimise the outcome after joint replacement surgery.

Entities:  

Mesh:

Year:  2009        PMID: 19190046     DOI: 10.1302/0301-620X.91B2.20765

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  54 in total

Review 1.  Use of patient-reported outcomes in the context of different levels of data.

Authors:  Ola Rolfson; Alastair Rothwell; Art Sedrakyan; Kate Eresian Chenok; Eric Bohm; Kevin J Bozic; Göran Garellick
Journal:  J Bone Joint Surg Am       Date:  2011-12-21       Impact factor: 5.284

Review 2.  Surgical management of osteoarthritis.

Authors:  Jeffrey N Katz; Brandon E Earp; Andreas H Gomoll
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-09       Impact factor: 4.794

3.  What Preoperative Factors are Associated With Not Achieving a Minimum Clinically Important Difference After THA? Findings from an International Multicenter Study.

Authors:  Pakdee Rojanasopondist; Vincent P Galea; James W Connelly; Sean J Matuszak; Ola Rolfson; Charles R Bragdon; Henrik Malchau
Journal:  Clin Orthop Relat Res       Date:  2019-06       Impact factor: 4.176

Review 4.  Pain, catastrophizing, and depression in the rheumatic diseases.

Authors:  Robert R Edwards; Christine Cahalan; Christine Calahan; George Mensing; Michael Smith; Jennifer A Haythornthwaite
Journal:  Nat Rev Rheumatol       Date:  2011-02-01       Impact factor: 20.543

Review 5.  Surgical management of hip osteoarthritis.

Authors:  Rajiv Gandhi; Anthony V Perruccio; Nizar N Mahomed
Journal:  CMAJ       Date:  2013-10-21       Impact factor: 8.262

6.  The role of emotional health in functional outcomes after orthopaedic surgery: extending the biopsychosocial model to orthopaedics: AOA critical issues.

Authors:  David C Ayers; Patricia D Franklin; David C Ring
Journal:  J Bone Joint Surg Am       Date:  2013-11-06       Impact factor: 5.284

7.  How do Orthopaedic Surgeons Address Psychological Aspects of Illness?

Authors:  Ana Maria Vranceanu; Reinier B Beks; Thierry G Guitton; Stein J Janssen; David Ring
Journal:  Arch Bone Jt Surg       Date:  2017-01

8.  Risk factors for early revision after total hip arthroplasty.

Authors:  Christopher J Dy; Kevin J Bozic; Ting Jung Pan; Timothy M Wright; Douglas E Padgett; Stephen Lyman
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-06       Impact factor: 4.794

9.  Effect of an education programme for patients with osteoarthritis in primary care--a randomized controlled trial.

Authors:  Eva Ekvall Hansson; Malin Jönsson-Lundgren; Anne-Marie Ronnheden; Eva Sörensson; Asa Bjärnung; Leif E Dahlberg
Journal:  BMC Musculoskelet Disord       Date:  2010-10-25       Impact factor: 2.362

10.  Education attainment is associated with patient-reported outcomes: findings from the Swedish Hip Arthroplasty Register.

Authors:  Meridith E Greene; Ola Rolfson; Szilard Nemes; Max Gordon; Henrik Malchau; Göran Garellick
Journal:  Clin Orthop Relat Res       Date:  2014-02-19       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.